Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction

被引：0
|
作者：
Azin Alizadehasl
Mina Mohseni
Kamran Roudini
Parisa Firoozbakhsh
机构：
[1] Iran University of Medical Sciences,Cardio
[2] Imam Khomeini Hospital Complex,Oncology Research Center, Rajaie Cardiovascular Medical and Research Center
[3] Tehran University of medical Sciences,Department of Internal Medicine, Hematology and Medical Oncology Ward, Cancer Research Center, Cancer Institute
来源：
Cardio-Oncology | / 10卷
关键词：
Trastuzumab; Left ventricular dysfunction; Cardiotoxicity; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction
    Alizadehasl, Azin
    Mohseni, Mina
    Roudini, Kamran
    Firoozbakhsh, Parisa
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [2] Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction
    Yu, Anthony F.
    Yadav, Nandini U.
    Eaton, Anne A.
    Lung, Betty Y.
    Thaler, Howard T.
    Liu, Jennifer E.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    ONCOLOGIST, 2015, 20 (10) : 1105 - 1110
  • [3] Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma
    Szmit, Sebastian
    Jurczak, Wojciech
    Zaucha, Jan Maciej
    Drozd-Sokolowska, Joanna
    Spychalowicz, Wojciech
    Joks, Monika
    Dlugosz-Danecka, Monika
    Torbicki, Adam
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (11) : 791 - 799
  • [4] Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapy
    Yao, Ren Jie Robert
    Gibson, Jordan
    Simmons, Christine
    Davis, Margot K.
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [5] Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction
    Nowsheen, Somaira
    Aziz, Khaled
    Park, Jae Yoon
    Lerman, Amir
    Villarraga, Hector R.
    Ruddy, Kathryn Jean
    Herrmann, Joerg
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (15):
  • [6] Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapy
    Ren Jie Robert Yao
    Jordan Gibson
    Christine Simmons
    Margot K. Davis
    Cardio-Oncology, 7
  • [7] Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer
    Yoon, Hyun Ju
    Kim, Kye Hun
    Kim, Jong Yoon
    Park, Hyuk Jin
    Cho, Jae Yeong
    Hong, Young Joon
    Park, Hyung Wook
    Kim, Ju Han
    Ahn, Youngkeun
    Jeong, Myung Ho
    Cho, Jeong Gwan
    Park, Jong Chun
    JOURNAL OF BREAST CANCER, 2016, 19 (04) : 402 - 409
  • [8] Serial Measurements of Left Ventricular Systolic and Diastolic Function by Cardiac Magnetic Resonance Imaging in Patients with Early Stage Breast Cancer on Trastuzumab
    Song, Lan
    Brezden-Masley, Christine
    Ramanan, Venkat
    Ghugre, Nilesh
    Barfett, Joseph J.
    Chan, Kelvin K. W.
    Haq, Rashida
    Petrella, Teresa
    Dhir, Vinita
    Jimenez-Juan, Laura
    Chacko, Binita Riya
    Kotha, Vamshi
    Connelly, Kim A.
    Yan, Andrew T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (07) : 1173 - 1179
  • [9] Safety of orbital atherectomy in patients with left ventricular systolic dysfunction
    Shlofmitz, Evan
    Meraj, Perwaiz
    Jauhar, Rajiv
    Sethi, Sanjum S.
    Shlofmitz, Richard A.
    Lee, Michael S.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (05) : 415 - 420
  • [10] QRS Duration and Echocardiographic Evidence of Left Ventricular Dyssynchrony in Patients with Left Ventricular Systolic Dysfunction
    Ahmed, Hafeez
    Tai, Javed Majid
    Khan, Sohail Abrar
    Yousuf, Muniza
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (03): : 146 - 149
12345